Home > Insider Trading > Filing (0001093557-21-000257)

Filing Details

Accession Number:: 0001093557-21-000257
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-11-16 13:11:59
Reporting Period:: 2021-11-15

Accepted Time:: 2021-11-16 13:11:59
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1093557	Dexcom Inc	DXCM	Surgical & Medical Instruments & Apparatus (3841)	330857544

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1286858	R Kevin Sayer	6340 Sequence Drive San Diego CA 92121	Chairman, Ceo & President	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2021-11-12	3,000	$0.00	87,705	No	5	G	Direct
Common Stock	Disposition	2021-11-15	222	$644.59	87,483	No	4	S	Direct
Common Stock	Disposition	2021-11-15	250	$645.01	87,233	No	4	S	Direct
Common Stock	Disposition	2021-11-15	200	$646.58	87,033	No	4	S	Direct
Common Stock	Disposition	2021-11-15	1,350	$647.92	85,683	No	4	S	Direct
Common Stock	Disposition	2021-11-15	878	$649.02	84,805	No	4	S	Direct
Common Stock	Disposition	2021-11-15	50	$652.36	84,755	No	4	S	Direct
Common Stock	Disposition	2021-11-15	50	$654.00	84,705	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	5	G	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

The transaction represents a gift by the Reporting Person of 3,000 shares to a charitable donor advised fund.
Included in this number are 36,385 unvested restricted stock units, 13,445 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 16,968 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 5,972 of which were granted on March 8, 2019 and shall vest through March 8, 2022.
On July 31, 2020, Mr. Sayer adopted a 10b5-1 Plan, which was amended effective June 15, 2021. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The shares set forth above were sold pursuant to the 10b5-1 Plan.
This transaction was executed in multiple trades at prices ranging from $643.86 to $644.68. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
This transaction was executed in multiple trades at prices ranging from $644.99 to $645.02. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
This transaction was executed in multiple trades at prices ranging from $646.57 to $646.58. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
This transaction was executed in multiple trades at prices ranging from $647.64 to $648.53. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
This transaction was executed in multiple trades at prices ranging from $648.64 to $649.475. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.